Researchers have called it the “Hispanic paradox”: When it comes to breast cancer, prostate cancer and heart disease, Latino patients in the U.S. survive longer after diagnosis than their non-Latino white and black counterparts — even though studies have found they tend to have fewer resources and less access to care than non-Latino whites.
It's the same for lung cancer, said scientists at the Miller School of Medicine at the University of Miami in a paper published online Monday by the journal Cancer.
Querying a vast database that tracks U.S. cancer cases, the researchers looked at 172,398 patients diagnosed with non-small cell lung cancer, a common subtype of the disease, in the U.S. from 1988 to 2007.
Overall, the 18,206 Latino patients had a 15% lower risk of dying during the study than the non-Latino white patients. Black patients were slightly more likely to die than non-Latino white patients.